Blood test for early signs of Alzheimer's disease
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study looks at tiny particles in the blood that may show early signs of Alzheimer's disease. It aims to help with earlier diagnosis and monitoring, which could lead to better care and treatment opportunities.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 55 and 80 years old.
- You or a caregiver can provide informed consent.
- You have a reliable study partner (someone who can accompany you and report on your condition).
- You do not have any other major neurological or psychiatric conditions.
- You have not taken part in studies involving amyloid-targeting treatments before.
- You do not have significant inflammatory diseases or take immunosuppressive medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with probable Alzheimer's disease to see how certain blood biomarkers relate to their symptoms. It may help doctors better understand the disease and tailor care.
This study is testing whether a simple blood test can help doctors diagnose Alzheimer's disease earlier and more accurately. It's for people who are having memory or thinking problems and are visiting a memory clinic.
This study tests whether a simple blood test can help detect Alzheimer's disease in people who visit their primary care doctor with memory concerns. It aims to improve early diagnosis at the community level.
This study screens people aged 60–80 for early signs of Alzheimer's disease in a community setting. Researchers will ask you questions and may perform brain imaging to understand who might benefit from early detection and treatment.
This study is testing whether a simple blood test can help diagnose Alzheimer's disease and predict how the disease will progress. If you have memory or thinking problems that have been getting worse, you may be able to join.
This study is testing whether a simple blood draw can help spot early signs of Alzheimer's disease. It aims to include people from diverse backgrounds who do not currently have memory problems, which may help make early detection more accessible for everyone.
Hear when a new Subjective Cognitive Decline (SCD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.